PT - JOURNAL ARTICLE AU - Hannelore Neuhauser AU - Angelika Schaffrath Rosario AU - Hans Butschalowsky AU - Sebastian Haller AU - Jens Hoebel AU - Janine Michel AU - Andreas Nitsche AU - Christina Poethko-Müller AU - Franziska Prütz AU - Martin Schlaud AU - Hans W. Steinhauer AU - Hendrik Wilking AU - Lothar H. Wieler AU - Lars Schaade AU - Stefan Liebig AU - Antje Gößwald AU - Markus M. Grabka AU - Sabine Zinn AU - Thomas Ziese TI - Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study AID - 10.1101/2021.11.22.21266711 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.22.21266711 4099 - http://medrxiv.org/content/early/2021/11/24/2021.11.22.21266711.short 4100 - http://medrxiv.org/content/early/2021/11/24/2021.11.22.21266711.full AB - Pre-vaccine SARS-CoV-2 seroprevalence data from Germany are scarce outside hotspots, and socioeconomic disparities remained largely unexplored. The nationwide RKI-SOEP study with 15,122 adult participants investigated seroprevalence and testing in a supplementary wave of the Socio-Economic-Panel conducted predominantly in October-November 2020. Self-collected oral-nasal swabs were PCR-positive in 0.4% and Euroimmun anti-SARS-CoV-2-S1-IgG ELISA from dry capillary blood in 1.3% (95% CI 0.9-1.7%, population-weighted, corrected for sensitivity=0.811, specificity=0.997). Seroprevalence was 1.7% (95% CI 1.2-2.3%) when additionally adjusting for antibody decay. Overall infection prevalence including self-reports was 2.1%. We estimate 45% (95% CI 21-60%) undetected cases and analyses suggest lower detection in socioeconomically deprived districts. Prior SARS-CoV-2 testing was reported by 18% from the lower educational group compared to 25% and 26% from the medium and high educational group (p<0.0001). Symptom-triggered test frequency was similar across educational groups. However, routine testing was more common in low-educated adults, whereas travel-related testing and testing after contact with an infected person was more common in highly educated groups. In conclusion, pre-vaccine SARS-CoV-2-seroprevalence in Germany was very low. Notified cases appear to capture more than half of infections but may underestimate infections in lower socioeconomic groups. These data confirm the successful containment strategy of Germany until winter 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe RKI-SOEP study was funded by the German Federal Ministry of Health (reference number: ZMVI1-2520COR402). Jens Hoebel has received funding from the German Research Foundation for research on socioeconomic inequalities in health during the COVID-19 pandemic (INHECOV project; reference number: HO 6565/2-1). ). Sabine Zinn acknowledge funding by the German Research Foundation for the project 'The consequences of SARS-CoV-2 for societal inequalities' (reference numbers: ZI 1535/1-1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval was obtained from the ethics committee of the Berlin Doctors' Council (reference ID Eth-33/20).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data cannot be made publicly available because informed consent from participants did not cover public deposition of data. However, the dataset underlying the analysis in this article is archived in the SOEP Research Data Centre (https://www.diw.de/en/diw_01.c.601584.en/data_access.html) in Berlin and can be accessed on site upon reasonable request.